65,437 trials
Amblyopia · Strabismus
Primary: Detection of Amblyopia and Strabismus in Children Ages 2-5 Using Automated Pediatric Vision Scanner Device — 6; 249; 0; 45 Participants
Delirium · Delirium, Dementia, Amnestic, Cognitive Disorders · Delayed Emergence From Anesthesia
Primary: Number of Participants With Delirium During Two Days Following Surgery — 3; 2 Participants
Uterine Fibroids · Heavy Menstrual Bleeding
Primary: Percentage of Participants Meeting the Criteria for Responder — 85.7; 66.7; 89.4; 87.9 percentage of participants
Uterine Fibroids · Heavy Menstrual Bleeding
Primary: Percentage of Participants Meeting the Criteria for Responder — 10.5; 76.9; 76.5 percentage of participants — p=< 0.001
Active Rheumatoid Arthritis
Primary: Number of Patients With Remission, Low, Moderate or High Disease Activity (in Terms of CDAI Scores) in Visits 1 and 6. — 0; 70; 10; 116 Participants
HIV-1 Infection
Primary: Impact of Two Weeks of Disulfiram, as Measured by the Fold Change in the Infectious Units Per Million Cells (IUPM) Between Baseline and Week 12 — 1.16 Fold change in IUPM
Rhinitis, Allergic, Seasonal
Primary: Change From Pre-Exposure in Mean Total 3 Nasal Symptom Score (3TNSS) 120 to 180 Minutes After Start of Cedar Pollen Exposure on Day 183 — 2.04; 1.91; 1.98 units on a…
Spinal Cord Injuries
Primary: American Spinal Injury Association (ASIA) Total Score at the Fourth Follow-up — 183.88 score
Cystic Fibrosis
Primary: Number of Participants With Critical Use Errors and Close Calls Associated With the Simulated Inhalation of One Dose Using TOBI Podhaler — 4 Participants
Stroke
Primary: National Institutes of Health Stroke Scale (NIHSS) — 3.8; 2.7 score on a scale
Sleep Disordered Breathing · Sleep Hypopnea · Sleep Apnea
Primary: Number of Participants With Apnea Hypopnea Index (AHI) Severity Improvement — 8 Participants — p=<.05
Multiple Sclerosis
Primary: Percentage of Participants With Infusion-related Reaction (IRR) Treated With 600 mg IV Ocrelizumab — 0 Percentage of Participants
Heart Failure · Chronic Heart Failure With Reduced Ejection Fraction
Primary: Time to First Occurrence of Composite Endpoint of Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization — 33.6; 37.8 Parts w/ event per 100 part-yrs at risk…
Hearing Loss
Primary: Specificity (%) of Transimpedance Measurement to Identify Electrode Fold-over — 98.6 Percentage of ears
Kidney Transplantation
Primary: Percentage of Participants Who Were Positive for de Novo DSA (dnDSA) or Immune Activation (IA) Occurrence — 35.6; 34.4 percentage of participants — p=0.5777